Roland Seiler, MD, on Bladder Cancer: Subtypes and Treatment Response

2017 Genitourinary Cancers Symposium
Tweet this page

Roland Seiler, MD, of the University of British Columbia, discusses a way to identify molecular subtypes of muscle-invasive bladder cancer, the varying responses to cisplatin-based neoadjuvant chemotherapy, and which patients show the most benefit. (Abstract 281)

Advertisement

Advertisement



Advertisement